You are here: Industry Insights > IBD

News List

Inflammatory Bowel Disease Ups Risk for Serious Viral Infections drugs
December 17, 2019
Patients with inflammatory bowel disease (IBD) have a threefold higher risk for systemic serious viral infections (SVIs) compared with the general population ...
Risk for Developing Idiopathic Pulmonary Fibrosis Up in IBD drugs
September 26, 2019
Patients with inflammatory bowel disease (IBD), especially male patients, have an increased risk for development of idiopathic pulmonary fibrosis (IPF) ...
Lilly's first crowdsourced digital health contest seeks solutions for IBD fiercepharma
August 22, 2019
Eli Lilly is firing up its first innovation challenge for digital health, seeking technology solutions for inflammatory bowel disease. Lilly’s contest will accept entries through midnight on Sept. 30.
Childhood-Onset IBD Ups Risk for Psychiatric Morbidity drugs
August 21, 2019
Childhood-onset inflammatory bowel disease (IBD) is associated with an increased risk for psychiatric morbidity, including suicide attempt, according to a study published online in JAMA Pediatrics.
Etanercept Tx for Autoimmune Disease May Up Risk for IBD drugs
July 16, 2019
Etanercept Tx for Autoimmune Disease May Up Risk for IBD.
Negative Cognitive Bias May Be Key to Depression in Active IBD drugs
July 12, 2019
Negative Cognitive Bias May Be Key to Depression in Active IBD.
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations drugs
June 17, 2019
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations.
Protagonist Therapeutics Expands PTG-200 Collaboration Agreement with Janssen to Include Second Generation Oral IL-23 Receptor Antagonists firstwordpharma
May 09, 2019
Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced the expansion of its worldwide license and collaboration agreement with Janssen Biotech, Inc. for the co-development and commercialization of PTG-200, Protagonist's first-in-class ...
NICE backs PredictImmune's IBD prognosis test pharmatimes
April 02, 2019
PredictImmune has announced that the National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) on the use of its PredictSURE IBD technology, for the prognosis of inflammatory bowel disease.
Cimzia maker UCB takes next step in pregnancy initiative for women with IBD with 'Parenthood Project' campaign fiercepharma
February 24, 2019
Thanks to worries and misconceptions about their health, women with inflammatory bowel disease are up to three times more likely than other women to choose not to have children.

Previous page 1 2 3 Next page